½ÃÀ庸°í¼­
»óǰÄÚµå
1301223

Àçó¸® ÀÇ·á±â±â ½ÃÀå ±Ô¸ð, Á¡À¯À² ¹× µ¿Ç⠺м® º¸°í¼­ : Á¦Ç°º°, À¯Çüº°, ÃÖÁ¾ ¿ëµµº°, ºÎ¹®º° µ¿Çâ(2023³â-2030³â)

Reprocessed Medical Devices Market Size, Share & Trends Analysis Report By Product (Cardiovascular, Laparoscopic), By Type (Third-party, In-house) By End-use (Hospitals, Home Healthcare), And Segment Forecasts, 2023 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 100 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Àçó¸® ÀÇ·á±â±â ½ÃÀå ¼ºÀå ¹× µ¿Çâ

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¼¼°è Àçó¸® ÀÇ·á±â±â ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 80¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2023³âºÎÅÍ 2030³â±îÁö 16.8%ÀÇ CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Àú·ÅÇϰí È¿°úÀûÀÎ ÀÇ·á±â±â¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í ÀÇ·á ½Ã¼³¿¡¼­ ¹ß»ýÇÏ´Â ÀÇ·á Æó±â¹° Áõ°¡¿¡ ´ëÇÑ ¿ì·Á°¡ ³ô¾ÆÁö¸é¼­ ½ÃÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¶ÇÇÑ, ÀÌ·¯ÇÑ Àåºñ¿Í °ü·ÃµÈ Àå±âÀûÀÎ ºñ¿ë È¿À²¼ºÀº ¿ø·¡ Àåºñ¿Í ºñ±³ÇÏ¿© ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÇ·á±â±â Àç°¡°øÀº ÀÇ·á ±â°üµé »çÀÌ¿¡¼­ ºñ¿ë Àý°¨ ¼ö´ÜÀ¸·Î Á¡Á¡ ´õ ³Î¸® º¸±ÞµÇ°í ÀÖÀ¸¸ç, AMDR(Association of Medical Device Reprocessors)¿¡ µû¸£¸é, ÀÌ·¯ÇÑ Àç°¡°ø Àåºñ´Â ÀϹÝÀûÀ¸·Î »õ Àåºñº¸´Ù 30-50% Àú·ÅÇÕ´Ï´Ù. º´¿ø ¹× ±âŸ ÀÇ·á ½Ã¼³Àº ÀÌ ºñ¿ë È¿À²ÀûÀÎ ÀÚ¿øÀ» Ȱ¿ëÇÏ¿© ¼­ºñ½º¸¦ °³¼±ÇÏ°í ±â¼úÀ» ¹ßÀü½ÃŰ´Â µ¥ Ȱ¿ëÇϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ ÀÇ·áÀÇ ÁúÀ» º¸ÀåÇÏ´Â µ¿½Ã¿¡ ÀÎ·Â Ãæ¿ø ¹× Àåºñ ±³Ã¼¿Í °°Àº Áß¿äÇÑ ºÐ¾ß¿¡ ÀÚ±ÝÀ» ÅõÀÔÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ AMDRÀÌ ¹ßÇ¥ÇÑ µ¥ÀÌÅÍ¿¡ µû¸£¸é º´¿øÀº ¹Ì±¹ ¿Â½Ç°¡½º(GHG) ¹èÃâ·®ÀÇ 8.5%, ¼¼°è ¿Â½Ç°¡½º ¹èÃâ·®ÀÇ 5%¸¦ Â÷ÁöÇÕ´Ï´Ù. ¿¬±¸¿¡ µû¸£¸é ÀÌ·¯ÇÑ ¹èÃâÀº ¹Ì±¹ÀÇ Æò±Õ ¼ö¸íÀ» 388,000³â ´ÜÃà½ÃŲ °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ÇÁ¶ó¿îÈ£ÆÛ ȯ°æ, ¾ÈÀü ¹× ¿¡³ÊÁö ±â¼ú ¿¬±¸¼Ò(Fraunhofer Institute for Environmental, Safety, and Energy Technology)ÀÇ 2021³â ¿¬±¸¿¡ µû¸£¸é, Àçó¸® ÀÇ·á±â±â¸¦ »ç¿ëÇÔÀ¸·Î½á ¸¦ »ç¿ëÇϸé Áö±¸ ¿Â³­È­¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» 40%±îÁö Å©°Ô ÁÙÀÏ ¼ö ÀÖ°í, ¿ÀÁ¸Ãþ ÆÄ±«¸¦ 90%±îÁö ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, À¯ÇÑÇÑ »ý¹° ÀÚ¿øÀÇ »ç¿ëÀ» 29%±îÁö ÁÙÀÏ ¼ö ÀÖ´Ù°í °á·ÐÁö¾ú½À´Ï´Ù. ±×·¯³ª ¼¼°èÀûÀ¸·Î ÀÇ·á Æó±â¹° Áõ°¡´Â Å« ¹®Á¦°¡ µÇ°í ÀÖ½À´Ï´Ù.

Àç°¡°øÀº Æó±â¹°À» ÁÙÀ̰í Á¦Ç° ¼ö¸íÀ» ¿¬ÀåÇÏ¿© ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ÀÇ·á±â±â Àçó¸® ¾÷üµéÀº Æó±â¹° °ü¸®¸¦ °³¼±Çϰí ÀϹÝÀÎ, ȯÀÚ, ÀÇ·áÁø ¹× Æó±â¹° ó¸® ÀÛ¾÷ÀÚÀÇ °Ç°­ À§ÇèÀ» ¹æÁöÇϱâ À§ÇØ Áö¼Ó °¡´ÉÇÑ ¼Ö·ç¼ÇÀ» µµÀÔÇϱ⠽ÃÀÛÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ¸ðµç ¿äÀεéÀÌ ¿¹Ãø ±â°£ µ¿¾È »ê¾÷ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, Arjo, Cardinal, Medline, Stryker¿Í °°Àº À¯¸í ±â¾÷ÀÇ ÀÚȸ»ç¸¦ Æ÷ÇÔÇÑ ¿©·¯ ÀÇ·á±â±â ȸ»çµéÀº Áö¼Ó°¡´É¼º ³ë·ÂÀÇ ÀÏȯÀ¸·Î ÀÏȸ¿ë ÀÇ·á±â±â(SUD) ÀçÁ¦Á¶(SUD)¸¦ ÀçÁ¦Á¶Çϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 1¿ù Vanguard AG´Â ¿µ±¹¿¡¼­ °¡Àå Å©°í À¯¸íÇÑ ÀÇ·á ±â°ü Áß ÇϳªÀÎ Leeds Teaching Hospitals NHS Trust¿ÍÀÇ Àü·«Àû Á¦ÈÞ¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ Á¦ÈÞ´Â ºñ¿ëÀ» Àý°¨ÇÏ°í º¸´Ù Áö¼Ó °¡´ÉÇÑ ÀÇ·á ȯ°æÀ» ÃËÁøÇϱâ À§ÇØ ÀçÁ¦Á¶µÈ ÀÇ·á ÀåºñÀÇ »ç¿ëÀ» ÃËÁøÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù.

Àçó¸® ÀÇ·á±â±â ½ÃÀå ÇÏÀ̶óÀÌÆ®

  • Á¦Ç°º°·Î´Â ½ÉÇ÷°ü ¼ö¼ú ¹× Áø´Ü¿¡ ³Î¸® »ç¿ëµÇ´Â Á¦Ç°À¸·Î ÀÎÇØ ½ÉÇ÷°ü ºÎ¹®ÀÌ Àüü ¸ÅÃâÀÇ 55% ÀÌ»óÀ» Â÷ÁöÇÏ¸ç °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù.
  • 2022³â, Á¦3ÀÚ Àçó¸® À¯ÇüÀÌ 84% ÀÌ»óÀÇ °¡Àå Å« ¼öÀÍ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÊ. ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü°¡ ºñ¿ëÀ» Àý°¨Çϰí ÀÇ·á Æó±â¹°À» ÃÖ¼ÒÈ­Çϱâ À§ÇØ ³ë·ÂÇÔ¿¡ µû¶ó ÃÖ±Ù ¸î ³âµ¿¾È Ÿ»ç Àçó¸® À¯ÇüÀÌ Á¡Á¡ ´õ ³Î¸® º¸±ÞµÇ°í ÀÖ½À´Ï´Ù.
  • ÃÖÁ¾ ¿ëµµº°·Î´Â º´¿ø ºÎ¹®ÀÌ 2022³â 40% ÀÌ»óÀÇ ³ôÀº ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â ÀÚ¿ø »ç¿ëÀÚ¿¡ ÀÇÇÑ ´ë·® Æó±â¹° ¹ß»ýÀ¸·Î ÀÎÇØ º´¿ø ³» ¹× Á¦3ÀÚ Àç°¡°øÀÌ Áõ°¡Ç߱⠶§¹®ÀÔ´Ï´Ù. ¾Õ¼­ ¾ð±ÞÇÑ ¿äÀÎÀº º´¿øÀÌ ÁöÃâÀ» ¾ïÁ¦ÇÒ ¼ö ÀÖ´Â À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù.
  • ºÏ¹Ì´Â ¼¼°è ½ÃÀåÀÇ 46% ÀÌ»óÀ¸·Î °¡Àå Å« ¸ÅÃâ ºñÁßÀ» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. Æó±â¹° ¹ß»ýÀ» ¾ïÁ¦ÇØ¾ß ÇÒ Çʿ伺ÀÌ Áõ°¡ÇÏ°í Æó±â¹° ¸Å¸³Áö Áõ°¡·Î ÀÎÇÑ ÀáÀçÀû ȯ°æ ÇÇÇØ´Â ÀÌ Áö¿ª ½ÃÀåÀ» À̲ô´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

  • ½ÃÀå ¼¼ºÐÈ­¿Í ¹üÀ§
  • Á¶»ç ¹æ¹ý
  • Á¤º¸ ¶Ç´Â µ¥ÀÌÅÍ ºÐ¼®
  • ½ÃÀå Çü¼º°ú °ËÁõ
  • ¸ðµ¨ »ó¼¼
  • 2Â÷ Á¤º¸ ¸®½ºÆ®
  • ¾à¾î ¸®½ºÆ®
  • ¸ñÀû

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ÇöȲ
  • ºÎ¹® ÇöȲ
  • °æÀï ±¸µµ ÇöȲ

Á¦3Àå ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå ¼¼ºÐÈ­¿Í ¹üÀ§
  • ½ÃÀå °èÅë Àü¸Á
    • »óÀ§ ½ÃÀå Àü¸Á
    • °ü·Ã/º¸Á¶ÀûÀÎ ½ÃÀå Àü¸Á
  • ½ÃÀå µ¿Çâ°ú Àü¸Á
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • »ç¾÷ ȯ°æ ºÐ¼®
    • PESTLE ºÐ¼®
    • PorterÀÇ Five Forces ºÐ¼®
  • COVID-19ÀÇ ¿µÇ⠺м®

Á¦4Àå Àçó¸® ÀÇ·á±â±â ½ÃÀå : Á¦Ç° ÃßÁ¤¡¤µ¿Ç⠺м®

  • Àçó¸® ÀÇ·á±â±â ½ÃÀå : Á¦Ç° µ¿Ç⠺м®°ú ½ÃÀå Á¡À¯À²
  • Àçó¸® ÀÇ·á±â±â ½ÃÀå : ºÎ¹® ´ë½Ãº¸µå
  • ½ÉÀåÇ÷°ü¿ë ±â±â
    • Ç÷¾Ð Ä¿ÇÁ
    • Æ÷Áö¼Å´× µð¹ÙÀ̽º
    • ½ÉÀå ¾ÈÁ¤È­ µð¹ÙÀ̽º
    • Àü±â»ý¸®ÇÐ Áø´Ü¿ë Ä«Å×ÅÍ
    • ½ÉºÎÁ¤¸Æ Ç÷ÀüÁõ¿ë ¾Ð¹Ú ½½¸®ºê
    • Àü±â»ý¸®ÇÐ ÄÉÀ̺í
  • º¹°­°æ¿ë µð¹ÙÀ̽º
    • Harmonic Scalpels
    • Endoscopic Trocars
  • ¼ÒÈ­±â¿ë µð¹ÙÀ̽º
    • »ý°Ë °âÀÚ
    • ±âŸ
  • ÀÏ¹Ý ¼ö¼ú¿ë µð¹ÙÀ̽º
    • ¾Ð·Â ¹é
    • dz¼± ÀÎÇ÷¹ÀÌ¼Ç ÀåÄ¡
  • Á¤Çü¿Ü°ú¿ë µð¹ÙÀ̽º

Á¦5Àå Àçó¸® ÀÇ·á±â±â ½ÃÀå : À¯Çü ÃßÁ¤¡¤µ¿Ç⠺м®

  • Àçó¸® ÀÇ·á±â±â ½ÃÀå : À¯Çü µ¿Ç⠺м®°ú ½ÃÀå Á¡À¯À²
  • Àçó¸® ÀÇ·á±â±â ½ÃÀå : ºÎ¹® ´ë½Ãº¸µå
  • ½áµåÆÄƼ¿¡ ÀÇÇÑ Àçó¸®
  • ¿ø³» Àçó¸®

Á¦6Àå Àçó¸® ÀÇ·á±â±â ½ÃÀå : ÃÖÁ¾ ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®

  • Àçó¸® ÀÇ·á±â±â ½ÃÀå : ÃÖÁ¾ ¿ëµµ µ¿Ç⠺м®°ú ½ÃÀå Á¡À¯À²
  • Àçó¸® ÀÇ·á±â±â ½ÃÀå : ºÎ¹® ´ë½Ãº¸µå
  • º´¿ø
  • ÀçÅÃÄ¡·á
  • ±âŸ

Á¦7Àå Áö¿ª ºñÁî´Ï½º ºÐ¼®

  • Àçó¸® ÀÇ·á±â±â ½ÃÀå Á¡À¯À², Áö¿ªº°, 2022³â ¹× 2030³â
  • ºÏ¹Ì
    • ºÏ¹ÌÀÇ Àçó¸® ÀÇ·á±â±â ½ÃÀå, 2018³â-2030³â(100¸¸ ´Þ·¯)
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • À¯·´ÀÇ Àçó¸® ÀÇ·á±â±â ½ÃÀå, 2018³â-2030³â(100¸¸ ´Þ·¯)
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • µ§¸¶Å©
    • ½º¿þµ§
    • ³ë¸£¿þÀÌ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Àçó¸® ÀÇ·á±â±â ½ÃÀå, 2018³â-2030³â(100¸¸ ´Þ·¯)
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • ű¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ Àçó¸® ÀÇ·á±â±â ½ÃÀå, 2018³â-2030³â(100¸¸ ´Þ·¯)
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Àçó¸® ÀÇ·á±â±â ½ÃÀå, 2018³â-2030³â(100¸¸ ´Þ·¯)
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • Äí¿þÀÌÆ®

Á¦8Àå °æÀï ±¸µµ

  • Âü¿© ±â¾÷ °³¿ä
  • À繫 ½ÇÀû
  • ±â¾÷ ½ÃÀå ÇöȲ ºÐ¼®
  • Àü·« ¸ÅÇÎ
    • È®Àå
    • Ãëµæ
    • Çù¾÷
    • ½ÅÁ¦Ç° ¹ß¸Å
    • ÆÄÆ®³Ê½Ê
    • ±âŸ
  • Âü¿© ±â¾÷ °³¿ä
    • Stryker
    • INNOVATIVE HEALTH
    • NEsciettific Inc.
    • Medline Industries, LP.
    • Arjo
    • Vanguard AG.
    • Cardinal Health
    • SureTek Medical
    • Soma Tech Intl
    • Johnson &Johnson MedTech
LSH 23.07.24

Reprocessed Medical Devices Market Growth & Trends

The global reprocessed medical devices market size is expected to reach USD 8.0 billion by 2030, according to a new study by Grand View Research, Inc., registering a CAGR of 16.8% from 2023 to 2030. The increasing need for affordable & effective medical devices and growing concern regarding the rising amounts of medical waste generated by healthcare facilities are expected to drive the market. In addition, the long-term cost-efficiency associated with these devices as compared to that of the original device is expected to further drive the market growth. Medical device reprocessing has become an increasingly popular way of saving costs among healthcare organizations. According to the Association of Medical Device Reprocessors (AMDR), these reprocessed devices are typically 30-50% cheaper than new ones. Hospitals and other healthcare facilities take advantage of this cost-effective resource to enhance services and advance their technology.

It also allows them to allocate funds to important areas like hiring additional personnel or updating equipment, while still ensuring quality of care. Moreover, data published by the AMDR reveals that hospitals are responsible for 8.5% of the Greenhouse Gas (GHG) emissions in the U.S. and 5% of global outputs. Studies suggest these emissions reduce life expectancy in the U.S. by 388,000 disability-adjusted years. Over 80% of emissions come from the healthcare supply chain. A 2021 study conducted by the Fraunhofer Institute for Environmental, Safety, and Energy Technology concluded that using reprocessed medical equipment could drastically reduce the global warming impact of such devices by 40%, reduce ozone depletion by 90%, and diminish the utilization of the finite abiotic resources by 29%. The COVID-19 pandemic had a significant impact on the market. However, an increasing amount of medical waste around the world has become a major concern.

Reprocessing can help address this challenge by reducing waste and prolonging the life of products. Medical device reprocessors have begun introducing sustainable solutions to improve waste management and prevent health risks to the public, patients, healthcare staff, and waste workers. All such factors are expected to drive the industry growth during the forecast period. Several medical device companies, including subsidiaries of prominent organizations, such as Arjo, Cardinal, Medline, and Stryker, engage in remanufacturing Single-Use Devices (SUDs) as part of their sustainability initiatives. For instance, in January 2023, Vanguard AG announced its strategic partnership with Leeds Teaching Hospitals NHS Trust, one of the UK's largest and most prominent healthcare providers. This collaboration aims to promote the use of remanufactured medical devices to reduce costs and foster a more sustainable healthcare environment.

Reprocessed Medical Devices Market Highlights

  • Based on products, the cardiovascular segment held the largest share of over 55% of the total revenue owing to the extensive utilization of these products in cardiovascular surgeries and diagnostics
  • The third-party reprocessing type segment held the largest revenue share of over 84% in 2022. The practice of third-party reprocessing has become increasingly popular in recent years as healthcare providers seek to reduce costs and minimize medical waste
  • The hospitals end-use segment held a substantial revenue share of over 40% in 2022 owing to increased in-house and third-party reprocessing due to the massive waste produced through resource users. The aforementioned factor provides lucrative opportunities for hospitals to contain the expenditure
  • North America accounted for the largest revenue share of over 46% of the global market. The rising need to curtail waste generation and potential damage to the environment owing to the increasing waste landfills is a major factor driving the regional market

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Research Methodology
  • 1.3. Information or Data Analysis
  • 1.4. Market Formulation & Validation
  • 1.5. Model Details
  • 1.6. List of Secondary Sources
  • 1.7. List of Abbreviations
  • 1.8. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Driver Analysis
  • 3.5. Market Restraint Analysis
  • 3.6. Business Environment Analysis
    • 3.6.1. PESTLE Analysis
    • 3.6.2. Porter's Five Forces Analysis
  • 3.7. COVID-19 Impact Analysis

Chapter 4. Reprocessed Medical Devices Market: Product Estimates & Trend Analysis

  • 4.1. Reprocessed Medical Devices Market: Product Movement Analysis and Market Share
  • 4.2. Reprocessed Medical Devices Market: Segment Dashboard
  • 4.3. Cardiovascular Devices
    • 4.3.1. Cardiovascular devices market, 2018 - 2030 (USD Million)
    • 4.3.2. Blood Pressure Cuffs
      • 4.3.2.1. Blood Pressure Cuffs market, 2018 - 2030 (USD Million)
    • 4.3.3. Positioning Devices
      • 4.3.3.1. Positioning Devices market, 2018 - 2030 (USD Million)
    • 4.3.4. Cardiac Stabilization Devices
      • 4.3.4.1. Cardiac Stabilization Devices market, 2018 - 2030 (USD Million)
    • 4.3.5. Diagnostic Electrophysiology Catheters
      • 4.3.5.1. Diagnostic Electrophysiology Catheters market, 2018 - 2030 (USD Million)
    • 4.3.6. Deep Vein Thrombosis Compression Sleeves
      • 4.3.6.1. Deep Vein Thrombosis Compression Sleeves market, 2018 - 2030 (USD Million)
    • 4.3.7. Electrophysiology Cables
      • 4.3.7.1. Electrophysiology Cables market, 2018 - 2030 (USD Million)
  • 4.4. Laparoscopic Devices
    • 4.4.1. Laparoscopic devices market, 2018 - 2030 (USD Million)
    • 4.4.2. Harmonic Scalpels
      • 4.4.2.1. Harmonic Scalpels market, 2018 - 2030 (USD Million)
    • 4.4.3. Endoscopic Trocars
      • 4.4.3.1. Endoscopic Trocars market, 2018 - 2030 (USD Million)
  • 4.5. Gastroenterology Devices
    • 4.5.1. Gastroenterology devices market, 2018 - 2030 (USD Million)
    • 4.5.2. Biopsy Forceps
      • 4.5.2.1. Biopsy Forceps market, 2018 - 2030 (USD Million)
    • 4.5.3. Others
      • 4.5.3.1. Others market, 2018 - 2030 (USD Million)
  • 4.6. General Surgery Devices
    • 4.6.1. General surgery devices, market, 2018 - 2030 (USD Million)
    • 4.6.2. Pressure Bags
      • 4.6.2.1. Pressure Bags market, 2018 - 2030 (USD Million)
    • 4.6.3. Balloon Inflation Devices
      • 4.6.3.1. Balloon Inflation Devices market, 2018 - 2030 (USD Million)
  • 4.7. Orthopedic Devices
    • 4.7.1. Orthopedic devices market, 2018 - 2030 (USD Million)

Chapter 5. Reprocessed Medical Devices Market: Type Estimates & Trend Analysis

  • 5.1. Reprocessed Medical Devices Market: Type Movement Analysis and Market Share
  • 5.2. Reprocessed Medical Devices Market: Segment Dashboard
  • 5.3. Third-Party Reprocessing
    • 5.3.1. Third-party reprocessing market, 2018 - 2030 (USD Million)
  • 5.4. In-House Reprocessing
    • 5.4.1. In-house reprocessing market, 2018 - 2030 (USD Million)

Chapter 6. Reprocessed Medical Devices Market: End-Use Estimates & Trend Analysis

  • 6.1. Reprocessed Medical Devices Market: End-Use Movement Analysis and Market Share
  • 6.2. Reprocessed Medical Devices Market: Segment Dashboard
  • 6.3. Hospitals
    • 6.3.1. Hospitals market, 2018 - 2030 (USD Million)
  • 6.4. Home Healthcare
    • 6.4.1. Home healthcare market, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Reprocessed Medical Devices Market Share By Region, 2022 & 2030
  • 7.2. North America
    • 7.2.1. North America Reprocessed Medical Devices Market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. key country dynamics
      • 7.2.2.2. Competitive Scenario
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. U.S. Reprocessed Medical Devices Market, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada key country dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Canada Reprocessed Medical Devices Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Reprocessed Medical Devices Market, 2018 - 2030 (USD Million)
    • 7.3.2. Germany
      • 7.3.2.1. Germany key country dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. Germany Reprocessed Medical Devices Market, 2018 - 2030 (USD Million)
    • 7.3.3. UK
      • 7.3.3.1. UK key country dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. UK Reprocessed Medical Devices Market, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France key country dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. France Reprocessed Medical Devices Market, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Italy key country dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Italy Reprocessed Medical Devices Market, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Spain key country dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Spain Reprocessed Medical Devices Market, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark key country dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Denmark Reprocessed Medical Devices Market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden key country dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Sweden Reprocessed Medical Devices Market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Norway key country dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Norway Reprocessed Medical Devices Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Reprocessed Medical Devices Market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Japan key country dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Japan Reprocessed Medical Devices Market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. China key country dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. China Reprocessed Medical Devices Market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India key country dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. India Reprocessed Medical Devices Market, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea key country dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. South Korea Reprocessed Medical Devices Market, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Australia key country dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Australia Reprocessed Medical Devices Market, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand key country dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Thailand Reprocessed Medical Devices Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Reprocessed Medical Devices Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil key country dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Brazil Reprocessed Medical Devices Market, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Mexico key country dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Mexico Reprocessed Medical Devices Market, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Argentina key country dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Argentina Reprocessed Medical Devices Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Reprocessed Medical Devices Market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa key country dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. South Africa Reprocessed Medical Devices Market, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Saudi Arabia key country dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Saudi Arabia Reprocessed Medical Devices Market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. UAE key country dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. UAE Reprocessed Medical Devices Market, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait key country dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Kuwait Reprocessed Medical Devices Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant's Overview
  • 8.2. Financial Performance
  • 8.3. Company Market Position Analysis
  • 8.4. Strategy Mapping
    • 8.4.1. Expansion
    • 8.4.2. Acquisition
    • 8.4.3. Collaborations
    • 8.4.4. New Product Launches
    • 8.4.5. Partnerships
    • 8.4.6. Others
  • 8.5. Participant's overview
    • 8.5.1. Stryker
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. INNOVATIVE HEALTH
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. NEsciettific Inc.
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Medline Industries, LP.
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Arjo
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Vanguard AG.
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Cardinal Health
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. SureTek Medical
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Soma Tech Intl
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Johnson & Johnson MedTech
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦